ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Cetirizine Hydrochloride Syrup
News »
latest
by relevance
Wockhardt gets US FDA approval for ulcers syrup; stk up
Feb 27, 2009 at 10:41 | Source:
Moneycontrol.com
Wockhardt had touched an intraday high of Rs 82.90 and an intraday low of Rs 81.35. At 10:41 am, the share was quoting at Rs 82.00, up Rs 0.90, or 1.11% on the NSE. The company has got US FDA approval for ulcers and hyperacidity syrup Hydrochloride, reports CNBC-TV18. It was trading with volumes of 35,935 shares.
Ranbaxy gets approval for Cetirizine Hydrochloride
Apr 25, 2008 at 18:28
Ranbaxy receives final US FDA approval to manufacture and market Cetirizine Hydrochloride Oral Solution
Wockhardt launches allergy drug in US
Jan 02, 2008 at 09:02 | Source:
Business Line
Wockhardt Ltd has launched Cetirizine tablets in the US, after having received the regulatory approval to market different strengths of anti-allergy medicine Cetirizine Hydrochloride, reports Business Line.
Ranbaxy gets approval for Cetirizine Hydrochloride tabs
Dec 31, 2007 at 15:15 | Source:
Ranbaxy receives final approval to manufacture and market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
Ranbaxy gets approval to mfg Cetirizine Hydrochloride Syrup
Nov 05, 2006 at 13:00
Ranbaxy receives tentative USFDA approval to manufacture and market Cetirizine Hydrochloride Syrup
Wockhardt gets US FDA approval for ulcers syrup; stk up
Feb 27, 2009 at 10:41 | Source:
Moneycontrol.com
Wockhardt had touched an intraday high of Rs 82.90 and an intraday low of Rs 81.35. At 10:41 am, the share was quoting at Rs 82.00, up Rs 0.90, or 1.11% on the NSE. The company has got US FDA approval for ulcers and hyperacidity syrup Hydrochloride, reports CNBC-TV18. It was trading with volumes of 35,935 shares.
Ranbaxy gets approval for Cetirizine Hydrochloride
Apr 25, 2008 at 18:28
Ranbaxy receives final US FDA approval to manufacture and market Cetirizine Hydrochloride Oral Solution
Ranbaxy gets approval for Cetirizine Hydrochloride tabs
Dec 31, 2007 at 15:15 | Source:
Ranbaxy receives final approval to manufacture and market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
Wockhardt launches allergy drug in US
Jan 02, 2008 at 09:02 | Source:
Business Line
Wockhardt Ltd has launched Cetirizine tablets in the US, after having received the regulatory approval to market different strengths of anti-allergy medicine Cetirizine Hydrochloride, reports Business Line.
Ranbaxy gets approval to mfg Cetirizine Hydrochloride Syrup
Nov 05, 2006 at 13:00
Ranbaxy receives tentative USFDA approval to manufacture and market Cetirizine Hydrochloride Syrup
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window